Cannasouth Limited (NZX: CBD) Supply Activity Added to Cannasouth Commercial Licence

Cannasouth Limited’s wholly owned subsidiary Cannasouth Bioscience Limited has received approval for an additional activity under its commercial Medicinal Cannabis Licence by the Medicinal Cannabis Agency (Agency) for its facilities based in Hamilton. The new supply activity is additional to existing cultivation and possession for manufacture activities on the license.

This licence means Cannasouth is ready to distribute its imported own brand products, once registered with the Agency. Cannasouth submitted its product assessment applications for its first three products to the Agency in November 2020.

Please see the link below for details:

2021-04-19 Supply Activity added to Cannasouth Commercial Licence

Source: Cannasouth Limited

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

NZME celebrates significant digital subscription milestone
GSH - Acquisition of Viaduct venue
DGL - Delisting from the Main Board of NZX Limited
KPG Annual Meeting 2022 presentation and address
NZL - Completion of Retail Bookbuild
ArborGen Announces Board Change
Oceania announces $500m sustainability-linked loan
MFB - Nomination of Cecilia Robinson
29th June 2022 Morning Report
GSH Appointment of new Chairman